Precision Medicine Market to Grow at a CAGR of 12.60 by 2022 According to New Research
Advances and innovations in new medical technologies are laying the foundation for growth in the precision pharmaceutical market. Since President Barack Obama's announcement of the Precision Medicine Initiative in January 2017, much research and development has been done to develop accurate drugs, targeted therapies and laboratory tests. The main focus of current government initiatives is on oncology, but it is expected to target almost any therapeutic area that is affected by genetic mutations.
View full press release